- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- 13 Nov 20 424B3 Prospectus supplement
- 13 Nov 20 EFFECT Notice of effectiveness
- 10 Nov 20 S-4/A Registration of securities issued in business combination transactions (amended)
- 9 Nov 20 S-4/A Registration of securities issued in business combination transactions (amended)
- 22 Oct 20 S-4/A Registration of securities issued in business combination transactions (amended)
- 17 Sep 20 S-4/A Registration of securities issued in business combination transactions (amended)
- 12 Aug 20 S-4/A Registration of securities issued in business combination transactions (amended)
-
28 May 20 S-4 Registration of securities issued in business combination transactions
- 22 Oct 20 Registration of securities issued in business combination transactions (amended)
- 17 Sep 20 Registration of securities issued in business combination transactions (amended)
- 12 Aug 20 Registration of securities issued in business combination transactions (amended)
- 28 May 20 Registration of securities issued in business combination transactions
Exhibit 23.5
Independent Registered Public Accounting Firm’s Consent
We consent to the inclusion in this Registration Statement of AMERI Holdings, Inc. on Form S-4 of our report dated April 21, 2020, which report includes an explanatory paragraph relating to substantial doubt about the ability of Jay Pharma, Inc. to continue as a going concern, with respect to our audits of the financial statements of Jay Pharma, Inc. as of December 31, 2019 and 2018 and for each of the two years in the period ended December 31, 2019, which report appears in the joint proxy statement/prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading “Experts” in such joint proxy statement/prospectus.
/s/ Marcumllp
Marcumllp
New York, NY
May 27, 2020